Skip to main content

Sex Differences in Pediatric Poisonings by Age Group: a Toxicology Investigators’ Consortium (ToxIC) Analysis (2010–2016)

Abstract

Objective

To review pediatric poisonings evaluated at the bedside by medical toxicologists and reported in the ToxIC registry, by sex and age group.

Methods

Pediatric poisoning cases age ≤18 years, reported between January 2010 and December 2016, were reviewed. Descriptive statistics were used to describe study variables by age group and sex.

Results

A total of 12,699 cases were analyzed. There were 7517 females and 5182 males. Those < 2 years old represented 12.5% of the study group (n = 1584), 17.2% were 2–6 years old (n = 2178), 8.6% were 7–12 years old (n = 1097), and 61.7% were 13–18 years old (n = 7840). The most common primary reasons for encounter were intentional pharmaceutical with 4900 females and 1836 males; intentional non-pharmaceutical with 952 females and 1213 males; unintentional pharmaceutical with 539 females and 644 males; and unintentional non-pharmaceutical with 435 females and 593 males. Overall, pharmaceuticals were the most commonly involved agents, including analgesics (20.9% of cases) and antidepressants (11% of cases): 27.8% of females and 10.7% of males were reportedly exposed to an analgesic.13.7% of females and 7.0% of males were reportedly exposed to an antidepressant. Among 1584 cases under 2 years, there were 747 females and 837 males; among 2178 cases aged 2–6 years, there were 954 females and 1224 males; among 1097 cases aged 7–12 years, there were 555 females and 542 males; and among 7840 cases aged 13–18 years, there were 5261 females and 2579 males. Death was reported in 0.7% of the cases: 20 females and 18 males. 6.1% of cases were managed with intubation: 421 females and 351 males.

Conclusions

Sex-based characteristics of poisonings varied by age group among pediatric poisoning presentations reported to the ToxIC registry and further research is needed to determine implications for education and prevention efforts.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Bond GR, Woodward RW, Ho M. The growing impact of pediatric pharmaceutical poisoning. J Pediatr. 2012;160(2):265–70 e2e61.

    Article  Google Scholar 

  2. Toce MS, Burns MM. The poisoned pediatric patient. Pediatr Rev. 2017;38(5):207–20.

    Article  Google Scholar 

  3. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018;56(12):1213–415.

    Article  Google Scholar 

  4. Elzagallaai A, Greff M, Rieder M. Adverse drug reactions in children: the double-edged sword of therapeutics. Clin Pharmacol Ther. 2017;101(6):725–35.

    Article  CAS  Google Scholar 

  5. Levine M, Froberg B, Ruha AM, Burns-Ewald M, Yen M, Claudius IA, et al. Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit/hyperactivity disorder drugs in the United States. Clin Toxicol (Phila). 2013;51(3):147–50.

    Article  CAS  Google Scholar 

  6. Ghosh P, Pruitt C, Shah N, Kulkarni A, Slattery A, Nichols M. Unintentional opioid ingestions presenting to a pediatric emergency department. Pediatr Emerg Care. 2018. https://doi.org/10.1097/PEC.0000000000001709.

  7. Burghardt LC, Ayers JW, Brownstein JS, Bronstein AC, Ewald MB, Bourgeois FT. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatr. 2013;132(1):18–27.

    Article  Google Scholar 

  8. Patel AM, Wheeler DC, Rose SR, Nadpara PA, Pakyz AL, Carroll NV. Prevalence and characteristics of pediatric opioid exposures and poisonings in the United States. J Pediatr. 2019;206:148–55 e144.

    Article  CAS  Google Scholar 

  9. Tadros A, Layman SM, Davis SM, Bozeman R, Davidov DM. Emergency department visits by pediatric patients for poisoning by prescription opioids. Am J Drug Alcohol Abuse. 2016;42(5):550–5.

    Article  Google Scholar 

  10. Spiller HA, Ackerman JP, Spiller NE, Casavant MJ. Sex- and age-specific increases in suicide attempts by self-poisoning in the United States among youth and young adults from 2000 to 2018. J Pediatr. 2019;210:201–8.

    Article  Google Scholar 

  11. Sheikh S, Hendry P, Lynch S, Kalynych CJ, Aldridge P, Kraemer D. Poisonings with suicidal intent aged 0-21 years reported to poison centers 2003-12. West J Emerg Med. 2015;16(4):497–502.

    Article  Google Scholar 

  12. Shehnaz SI, Agarwal AK, Khan N. A systematic review of self-medication practices among adolescents. J Adolesc Health. 2014;55(4):467–83.

    Article  Google Scholar 

  13. Rhodes AE, Boyle MH, Bridge JA, Sinyor M, Links PS, Tonmyr L, et al. Antecedents and sex/gender differences in youth suicidal behavior. World J Psychiatry. 2014;4(4):120–32.

    Article  Google Scholar 

  14. Beauchamp GA, Carey JL, Adams T, Wier A, Colon MF, Cook M, et al. Sex differences in poisonings among older adults: an analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010 to 2016. Clin Ther. 2018;40(8):1366–74 e1368.

    Article  CAS  Google Scholar 

  15. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1–10.

    Article  Google Scholar 

  16. Farrugia LA, Rhyee SH, Campleman SL, Ruha AM, Weigand T, Wax PM, et al. The Toxicology Investigators Consortium Case Registry-the 2015 experience. J Med Toxicol. 2016;12(3):224–47.

    Article  CAS  Google Scholar 

  17. Cunningham RM, Walton MA, Carter PM. The major causes of death in children and adolescents in the United States. N Engl J Med. 2018;379(25):2468–75.

    Article  Google Scholar 

  18. Rhodes AE, Bethell J, Spence J, Links PS, Streiner DL, Jaakkimainen RL. Age-sex differences in medicinal self-poisonings: a population-based study of deliberate intent and medical severity. Soc Psychiatry Psychiatr Epidemiol. 2008;43(8):642–52.

    Article  Google Scholar 

  19. Qato DM, Alexander GC, Guadamuz JS, Lindau ST. Prescription medication use among children and adolescents in the United States. Pediatr. 2018;142(3).

  20. Sarchiapone M, Mandelli L, Iosue M, Andrisano C, Roy A. Controlling access to suicide means. Int J Environ Res Public Health. 2011;8(12):4550–62.

    Article  Google Scholar 

  21. Kang AM. Substances involved in suicidal poisonings in the United States. Suicide Life Threat Behav. 2019;49(5):1307–17.

    Article  Google Scholar 

  22. Finkelstein Y, Hutson JR, Wax PM, Brent J. Toxico-surveillance of infant and toddler poisonings in the United States. J Med Toxicol. 2012;8:263–6.

    Article  Google Scholar 

  23. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Beuhler MC, Rivers LJ, et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019;57(12):1220–413.

    Article  CAS  Google Scholar 

  24. Even KM, Armsby CC, Bateman ST. Poisonings requiring admission to the pediatric intensive care unit: a 5-year review. Clin Toxicol (Phila). 2014;52(5):519–24.

    Article  CAS  Google Scholar 

  25. Ruha AM, Kleinschmidt KC, Greene S, Spyres MB, Brent J, Wax P, et al. The epidemiology, clinical course, and management of Snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13(4):309–20.

    Article  Google Scholar 

  26. Shain B, Committee On A. Suicide and suicide attempts in adolescents. Pediatr. 2016;138(1).

  27. Langhinrichsen-Rohling J, Friend J, Powell A. Adolescent suicide, gender, and culture: a rate and risk factor analysis. Aggression and Violent Behav. 2009;14(5):402–14.

    Article  Google Scholar 

  28. Kloos A, Weller RA, Chan R, Weller EB. Gender differences in adolescent substance abuse. Curr Psychiatry Rep. 2009;11(2):120–6.

    Article  Google Scholar 

  29. Frommeyer G, Eckardt L. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol. 2016;13(1):36–47.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge Anita Kurt, PhD, Director of Research Operations at Lehigh Valley Health Network Department of Emergency and Hospital Medicine, for her oversight of this project; Lexis Laubach, Research Assistant, Department of Emergency and Hospital Medicine, for her assistance with manuscript preparation. The authors appreciate the leadership and support of ToxIC leadership including Jeffrey Brent, MD, PhD, Diane P. Calello, MD, and Paul M. Wax, MD. The authors would like also to acknowledge the efforts of Shae Duka, BS, for her statistical analysis and Lexis Laubach, BS, for her editorial assistance.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Gillian A. Beauchamp.

Ethics declarations

Conflicts of Interest

None.

Sources of Funding

This study, in part, was funded by an unrestricted grant, the Dorothy Rider Pool Trust for Health Research and Education community foundation grant (number 2017 1573-015).

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Beauchamp, G.A., Carey, J.L., Cook, M.D. et al. Sex Differences in Pediatric Poisonings by Age Group: a Toxicology Investigators’ Consortium (ToxIC) Analysis (2010–2016). J. Med. Toxicol. 16, 423–443 (2020). https://doi.org/10.1007/s13181-020-00781-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-020-00781-9

Keywords

  • Pediatrics
  • Medical toxicology
  • Poisonings
  • Sex differences